LIVE MARKET TRACKER :   BSE SENSEX   33230.40      |    NSE NIFTY 10244.10    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Corporate  :  Panacea Biotec planning to raise Rs 250 crore

Panacea Biotec planning to raise Rs 250 crore (26-Sep-2017)

Panacea Biotec is planning to raise Rs 250 crore by way of issue of equity shares and/or other securities. In this regards, the company is conducting Postal Ballot for obtaining approval of members for passing special resolution.

The Notice is being dispatched to the shareholders of the Company whose names appear in the Register of Members of the Company as on the cut-off date i.e. September 15, 2017 and the same is being sent to the members of the company through e-mail / post.

The company has also provided remote e-voting facility to the members to vote electronically through e-voting platform provided by NSDL.

Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.


Top News Today
Adlabs Entertainment in talks with three PE firms to raise Rs 650 crore: Report
(13-Dec-2017)

Adlabs Entertainment in talks with three PE firms to raise Rs 650 crore: ReportAdlabs Entertainment is reportedly in talks with three private equity (PE) firms, including Blackstone Group Warburg Pincus and TPG to raise about Rs 650 crore from financial investors as part of a two-pronged......click on news to read complete article.

Kridhan Infra inks SSA to increase stake in VNC
(13-Dec-2017)

Kridhan Infra inks SSA to increase stake in VNCKridhan Infra (KIL) has signed a Share Subscription Agreement (SSA) to significantly enhance its strategic stake in Vijay Nirman Company (VNC). Post the completion of the transaction, VNC will operate......click on news to read complete article.

Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets
(12-Dec-2017)

Alembic Pharma gets USFDAAlembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Darifenacin Extended-Release Tablets, 7.5 mg and 15......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.